{"entity":{"id":"nct04083599","kind":"trial","name":"GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of Pembrolizumab, Cisplatin, Carboplatin in non-small-cell lung cancer and small-cell lung cancer, run by Genmab, active and no longer recruiting.","summary":"GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors is a phase 1/2 interventional study registered as NCT04083599 by Genmab, with 350 participants enrolled, started 2019-09-17 and due to reach its primary completion in 2025-12-30. Interventions recorded: GEN1042, Pembrolizumab, Cisplatin, Carboplatin, 5-FU. Conditions listed: Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04083599","url":"https://clinicaltrials.gov/study/NCT04083599"}],"tags":["ctgov-ingest"],"related":[],"cancers":["nsclc","sclc","colorectal","melanoma","head-and-neck"],"sections":[],"technologies":[],"targets":[],"drugs":["pembrolizumab","cisplatin","carboplatin","flot","gemcitabine","paclitaxel"],"companies":["genmab"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT04083599","phase":"1/2","setting":"A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Subjects With Malignant Solid Tumors","sponsor":"Genmab","enrolled":350,"outcomes":[]},"route":"/trials/nct04083599/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"cisplatin","kind":"drug","name":"Cisplatin","route":"/drugs/cisplatin/"},{"id":"flot","kind":"drug","name":"FLOT (5-FU, leucovorin, oxaliplatin, docetaxel)","route":"/drugs/flot/"},{"id":"gemcitabine","kind":"drug","name":"Gemcitabine","route":"/drugs/gemcitabine/"},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"},{"id":"pembrolizumab","kind":"drug","name":"Pembrolizumab","route":"/drugs/pembrolizumab/"}],"company":[{"id":"genmab","kind":"company","name":"Genmab","route":"/companies/genmab/"}]}}